Clareo Health | A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
11–17
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Male or female subjects from 11 to 17 years old at the time of they start the study.
Subject must be healthy which will be determined by obtaining subject's medical history, receiving a physical examination and by judgment of the investigator.
You may not be if
Previous vaccination with any meningococcal serogroup B vaccine.
Previous vaccination with any HPV vaccine.
Contraindication to vaccination with Gardasil or any HPV vaccine.
